N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine

C115H115F3N24O8 — CID 158153100

IUPACN-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine
SMILESCOc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1
InChIInChI=1S/C30H27N5O2.C29H28N6O2.C28H31F3N6O2.C28H29N7O2/c1-34-21-23(19-32-34)30-20-31-28-13-12-24(17-29(28)33-30)35(14-8-7-11-22-9-5-4-6-10-22)25-15-26(36-2)18-27(16-25)37-3;1-34-17-20(15-32-34)29-16-31-27-8-7-21(13-28(27)33-29)35(22-11-23(36-2)14-24(12-22)37-3)18-19-10-25(19)26-6-4-5-9-30-26;1-35-17-20(14-33-35)27-15-32-25-5-4-21(12-26(25)34-27)37(22-10-23(38-2)13-24(11-22)39-3)16-19-6-8-36(9-7-19)18-28(29,30)31;1-33(2)28-8-6-7-20(31-28)18-35(22-11-23(36-4)14-24(12-22)37-5)21-9-10-25-26(13-21)32-27(16-29-25)19-15-30-34(3)17-19/h4-6,9-10,12-13,15-21H,8,14H2,1-3H3;4-9,11-17,19,25H,10,18H2,1-3H3;4-5,10-15,17,19H,6-9,16,18H2,1-3H3;6-17H,18H2,1-5H3/t;19-,25+;;/m.0../s1
InChIKeyFVIYRFABWRWJON-RXTQRVCCSA-N
MW2018.34 g/mol
LogP21.32
Rot. Bonds31

About N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine

N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine (PubChem CID 158153100) has the molecular formula C115H115F3N24O8 and a molecular weight of 2018.34 g/mol. Its IUPAC name is N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine.

Molecular Properties

Compound NameN-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine
PubChem CID158153100
Molecular FormulaC115H115F3N24O8
Molecular Weight2018.34 g/mol
Exact Mass2016.93
IUPAC NameN-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine
SMILESCOc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1
InChIInChI=1S/C30H27N5O2.C29H28N6O2.C28H31F3N6O2.C28H29N7O2/c1-34-21-23(19-32-34)30-20-31-28-13-12-24(17-29(28)33-30)35(14-8-7-11-22-9-5-4-6-10-22)25-15-26(36-2)18-27(16-25)37-3;1-34-17-20(15-32-34)29-16-31-27-8-7-21(13-28(27)33-29)35(22-11-23(36-2)14-24(12-22)37-3)18-19-10-25(19)26-6-4-5-9-30-26;1-35-17-20(14-33-35)27-15-32-25-5-4-21(12-26(25)34-27)37(22-10-23(38-2)13-24(11-22)39-3)16-19-6-8-36(9-7-19)18-28(29,30)31;1-33(2)28-8-6-7-20(31-28)18-35(22-11-23(36-4)14-24(12-22)37-5)21-9-10-25-26(13-21)32-27(16-29-25)19-15-30-34(3)17-19/h4-6,9-10,12-13,15-21H,8,14H2,1-3H3;4-9,11-17,19,25H,10,18H2,1-3H3;4-5,10-15,17,19H,6-9,16,18H2,1-3H3;6-17H,18H2,1-5H3/t;19-,25+;;/m.0../s1
InChIKeyFVIYRFABWRWJON-RXTQRVCCSA-N
XLogP21.32
TPSA293.46 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds31
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002018.34
LogP ≤ 521.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine?
The IUPAC name of N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine (CID 158153100) is N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine.
What is the SMILES notation for N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine?
The canonical SMILES for N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine is COc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.
What is the InChIKey of N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine?
The InChIKey is FVIYRFABWRWJON-RXTQRVCCSA-N. The full InChI is InChI=1S/C30H27N5O2.C29H28N6O2.C28H31F3N6O2.C28H29N7O2/c1-34-21-23(19-32-34)30-20-31-28-13-12-24(17-29(28)33-30)35(14-8-7-11-22-9-5-4-6-10-22)25-15-26(36-2)18-27(16-25)37-3;1-34-17-20(15-32-34)29-16-31-27-8-7-21(13-28(27)33-29)35(22-11-23(36-2)14-24(12-22)37-3)18-19-10-25(19)26-6-4-5-9-30-26;1-35-17-20(14-33-35)27-15-32-25-5-4-21(12-26(25)34-27)37(22-10-23(38-2)13-24(11-22)39-3)16-19-6-8-36(9-7-19)18-28(29,30)31;1-33(2)28-8-6-7-20(31-28)18-35(22-11-23(36-4)14-24(12-22)37-5)21-9-10-25-26(13-21)32-27(16-29-25)19-15-30-34(3)17-19/h4-6,9-10,12-13,15-21H,8,14H2,1-3H3;4-9,11-17,19,25H,10,18H2,1-3H3;4-5,10-15,17,19H,6-9,16,18H2,1-3H3;6-17H,18H2,1-5H3/t;19-,25+;;/m.0../s1.
What are the key properties of N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine?
N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine has a molecular weight of 2018.34 g/mol, XLogP of 21.32, 31 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3,5-dimethoxyphenyl)-N-[[6-(dimethylamino)-2-pyridinyl]methyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(4-phenylbut-3-ynyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[(1R,2R)-2-pyridin-2-ylcyclopropyl]methyl]quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]quinoxalin-6-amine is sourced from PubChem (CID 158153100), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).